Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco Dorsey Wright Momentum ETF
PDP
|
+$591M |
| 2 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$240M |
| 3 |
Boston Scientific
BSX
|
+$194M |
| 4 |
SCHW
Charles Schwab
SCHW
|
+$193M |
| 5 |
Clarivate
CLVT
|
+$158M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.25B |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$809M |
| 3 |
Willis Towers Watson
WTW
|
+$664M |
| 4 |
AstraZeneca
AZN
|
+$658M |
| 5 |
Microsoft
MSFT
|
+$573M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.19% |
| 2 | Financials | 6.48% |
| 3 | Consumer Discretionary | 5.4% |
| 4 | Healthcare | 5.05% |
| 5 | Communication Services | 4.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3801
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
$40.5B
| $345K | ﹤0.01% |
9,528
+7,858
| +471% | +$292K |
|
|
SCS
3802
DELISTED
Steelcase
SCS
| $344K | ﹤0.01% |
27,147
-11,520
| -30% | -$159K |
|
|
ONEM
3803
DELISTED
1Life Healthcare
ONEM
| $344K | ﹤0.01% |
17,023
+7,364
| +76% | +$189K |
|
3804
Gerdau
GGB
$9.74B
| $343K | ﹤0.01% |
87,884
-2,376
| -3% | -$10.3K |
|
3805
Clearwater Paper
CLW
$341M
| $341K | ﹤0.01% |
8,894
-251
| -3% | -$7.98K |
|
3806
Towne Bank
TOWN
$3.49B
| $341K | ﹤0.01% |
10,968
+5,342
| +95% | +$161K |
|
3807
ENI
E
$80.5B
| $340K | ﹤0.01% |
12,740
-77,004
| -86% | -$1.88M |
|
|
KNDI
3808
Kandi Technologies Group
KNDI
$65.7M
| $340K | ﹤0.01% |
76,390
-14,095
| -16% | -$71.3K |
|
|
PRVB
3809
DELISTED
Provention Bio, Inc. Common Stock
PRVB
| $338K | ﹤0.01% |
52,768
+34,394
| +187% | +$221K |
|
|
CHUY
3810
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
| $335K | ﹤0.01% |
10,611
-1,644
| -13% | -$53.9K |
|
3811
Fossil Group
FOSL
$288M
| $334K | ﹤0.01% |
28,214
+1,099
| +4% | +$14.2K |
|
|
PTRA
3812
DELISTED
Proterra Inc. Common Stock
PTRA
| $334K | ﹤0.01% |
32,996
+32,860
| +24,162% | +$371K |
|
3813
Vanguard ESG US Stock ETF
ESGV
$13.1B
| $333K | ﹤0.01% |
4,164
-896
| -18% | -$73.8K |
|
3814
PUT
Blink Charging
BLNK
$70.4M
| $329K | ﹤0.01% |
+11,500
| New | +$373K |
|
3815
Simulations Plus
SLP
$370M
| $328K | ﹤0.01% |
8,304
-1,398
| -14% | -$63.8K |
|
|
ORTX
3816
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
| $328K | ﹤0.01% |
14,276
+2,428
| +20% | +$72.2K |
|
3817
iShares Global Energy ETF
IXC
$2.77B
| $326K | ﹤0.01% |
12,158
-7,868
| -39% | -$197K |
|
3818
Movado Group
MOV
$849M
| $325K | ﹤0.01% |
10,331
+870
| +9% | +$27.8K |
|
3819
ARKO Corp
ARKO
$903M
| $323K | ﹤0.01% |
32,027
+2,386
| +8% | +$21.5K |
|
3820
REX American Resources
REX
$1.44B
| $323K | ﹤0.01% |
24,270
-12,120
| -33% | -$164K |
|
3821
Clearfield
CLFD
$420M
| $322K | ﹤0.01% |
7,299
+550
| +8% | +$23.1K |
|
3822
Forrester Research
FORR
$189M
| $322K | ﹤0.01% |
6,546
-2,443
| -27% | -$115K |
|
|
WKME
3823
DELISTED
WalkMe Ltd. Ordinary Shares
WKME
| $321K | ﹤0.01% |
+10,800
| New | +$308K |
|
3824
Yext
YEXT
$552M
| $320K | ﹤0.01% |
26,650
-9,644
| -27% | -$124K |
|
|
AMRS
3825
DELISTED
Amyris Inc.
AMRS
| $320K | ﹤0.01% |
23,288
+10,945
| +89% | +$157K |
|
Similar funds
Citigroup's Q3 2021 Portfolio in Review
As of Q3 2021, Citigroup held 6,611 positions worth $169B, up 1.9% from $166B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Citigroup deployed $5.8B of net new capital in Q3 2021, opening 423 new positions and adding to 2,034 existing holdings. Its largest new stake was Hennessy Capital Investment Corp. VI Unit: 9,095,000 shares worth $90.5M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 12% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $2.25B trimmed.
- Citigroup's largest Q3 2021 buy was Hennessy Capital Investment Corp. VI Unit: 9,095,000 shares worth $90.5M.
- Citigroup added most to Invesco Dorsey Wright Momentum ETF in Q3 2021, an estimated $591M increase.
- Citigroup's biggest Q3 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.25B.
- Citigroup fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $809M.
- Citigroup's ten largest holdings make up 25% of its $169B portfolio in Q3 2021.
- Citigroup opened 423 new positions and closed 793 in Q3 2021.
- Citigroup's portfolio value rose 1.9% quarter-over-quarter to $169B.
Based on Citigroup's 13F filing for Q3 2021, filed 10 Nov 2021.